3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: January 11, 2019
Period of Report: January 10, 2019
Accession Number: 0001735276-19-000015

View Document ↗ View on SEC.gov ↗